قالب:أجسام مضادة وحيدة النسيلة لعلاج الأورام

بشري ("-tumu-")	Adecatumumab^§ Ascrinvacumab^§ Cixutumumab^§ Conatumumab^§ Daratumumab Drozitumab^§ Duligotumab^§ Dusigitumab^§ Enfortumab vedotin^§ Enoticumab^§ Figitumumab^§ Ganitumab^† Glembatumumab vedotin^§ Intetumumab^§ Ipilimumab Iratumumab^§ Icrucumab^§ Lexatumumab^§ Lucatumumab^§ Mapatumumab^§ Narnatumab^§ Necitumumab Nesvacumab^§ Ofatumumab Olaratumab^† Panitumumab Patritumab^§ Pritumumab^§ Radretumab^§ Ramucirumab Rilotumumab^† Robatumumab^§ Seribantumab^§ Tarextumab^§ Teprotumumab^§ Tovetumab^§ Vantictumab^§ Vesencumab^§ Votumumab^§ Zalutumumab^† "-melu-" (الميلانوما) Flanvotumab^§
الفئران ("-tumo-")	Altumomab pentetate Anatumomab mafenatox Arcitumomab Bectumomab بليناتوموماب Detumomab Ibritumomab tiuxetan Minretumomab Mitumomab Moxetumomab pasudotox Naptumomab estafenatox Nofetumomab merpentan Pemtumomab^† Pintumomab Racotumomab Satumomab pendetide Solitomab Taplitumomab paptox Tenatumomab Tositumomab 3F8 "-govo-" (ورم المبيض) Abagovomab Igovomab Oregovomab "-pro-" (ورم البروستاتا) Capromab pendetide "-colo-" (ورم القولون) Edrecolomab Nacolomab tafenatox
كيمرية ("-tuxi-")	Amatuximab^§ Bavituximab^§ Brentuximab vedotin Cetuximab Derlotuximab biotin^§ Dinutuximab Ensituximab^§ Futuximab^§ Girentuximab^† Indatuximab ravtansine^§ Isatuximab^† Margetuximab^† Rituximab^# Siltuximab Ublituximab^§ "-mexi-" (الميلانوما): Ecromeximab^§
مؤنسن ("-tuzu-")	أبيتوزوماب^§ Alemtuzumab بڤاسيزوماب Bivatuzumab mertansine^§ Brontictuzumab^§ Cantuzumab mertansine^§ Cantuzumab ravtansine^§ Citatuzumab bogatox^§ Clivatuzumab tetraxetan Dacetuzumab^§ Demcizumab^§ Dalotuzumab^§ Denintuzumab mafodotin^§ Elotuzumab Emactuzumab^§ Emibetuzumab^§ Enoblituzumab^§ Etaracizumab^§ Farletuzumab^§ Ficlatuzumab^§ Gemtuzumab ozogamicin^‡ Imgatuzumab^§ Inotuzumab ozogamicin^† Labetuzumab^§ Lifastuzumab vedotin^§ Lintuzumab^§ Lorvotuzumab mertansine^§ Lumretuzumab^§ Matuzumab^§ Milatuzumab^§ Nimotuzumab^† Obinutuzumab Ocaratuzumab^§ Otlertuzumab^§ Onartuzumab^§ Oportuzumab monatox^§ Parsatuzumab^§ Pertuzumab Pinatuzumab vedotin^§ Polatuzumab vedotin^§ Sibrotuzumab^§ Simtuzumab^§ Tacatuzumab tetraxetan^§ Tigatuzumab^§ Trastuzumab Tucotuzumab celmoleukin^§ Vandortuzumab vedotin^§ Vanucizumab^§ Veltuzumab^§ Vorsetuzumab mafodotin^§ "-gozu-" (ورم المبيض) Sofituzumab vedotin^§
هجين فأر/جرذ ("-tumaxo-")	Catumaxomab Ertumaxomab^§
كيميري + مؤنسن ("-tuxizu-")	Depatuxizumab mafodotin^§ Ontuxizumab^§
بيطري ("-tuvet-")	Blontuvetmab^§ Tamtuvetmab^§

^#من الأدوية الأساسية. ^†يخضع لتجارب سريرية، وغير مصرح به من ادارة الغذاء والدواء. ^‡مسحوب من السوق. ^§التطوير اوقف.

This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.

To change this template's initial visibility, the |state= parameter may be used:

{{أجسام مضادة وحيدة النسيلة لعلاج الأورام|state=collapsed}} will show the template collapsed, i.e. hidden apart from its title bar.
{{أجسام مضادة وحيدة النسيلة لعلاج الأورام|state=expanded}} will show the template expanded, i.e. fully visible.